Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-08-061003
Filing Date
2008-11-04
Accepted
2008-11-04 16:34:54
Documents
1
Period of Report
2008-10-10

Document Format Files

Seq Description Document Type Size
1 v130463_ex.html 3  
1 v130463_ex.xml 3 2948
  Complete submission text file 0001144204-08-061003.txt   4842
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Issuer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 GREAT RING ROAD SANDY HOOK CT 06482
Business Address C/O PENNWEST PHARMACEUTICALS CO. 39 OLD RIDGEBURY ROAD, STE. 11 DANBURY CT 06810-5120 203 796-3701
GOOD JENNIFER L (Reporting) CIK: 0001229245 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51310 | Film No.: 081161251